...
首页> 外文期刊>Journal of Neuroimmunology: Official Bulletin of the Research Committee on Neuroimmunology of the World Federation of Neurology >Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy
【24h】

Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy

机译:炎症标志物与接受化疗乳腺癌患者认知功能的关联

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract Background Cancer-related cognitive impairment (CRCI) is often related to chemotherapy. Increased chronic inflammation is believed to play a key role in the development of CRCI related to chemotherapy but studies assessing this hypothesis specifically in patients receiving chemotherapy are rare. Methods We assessed several cognitive domains using the Cambridge Neuropsychological Test Automated Battery (CANTAB) in twenty-two breast cancer patients currently receiving chemotherapy. We also measured inflammatory cytokine and receptor (MCP-1, TNF-α, sTNFRI, sTNFRII) concentrations in patient sera using Luminex assays. These concentrations were log-transformed to obtain a normal distribution. Associations between log-transformed cytokines and cognition were evaluated using Pearson correlations and linear regression, taking into account relevant covariates. Results Increased concentrations of sTNFRI and sTNFRII were associated with poorer performance on the CANTAB Delayed Matching to Sample (DMS, tests visual memory). Increasing sTNFRI levels were negatively correlated with DMS percent correct (r=?0.47, p=0.029) and DMS percent correct after a 12 second (s) delay (r=?0.65, p=0.001). Increasing levels of sTNFRII negatively correlated with DMS percent correct after 12s delay (r=?0.57, p=0.006). After controlling for relevant demographic (i.e. age, education) and clinical variables (i.e. disease stage, regimen type), we found that increased sTNFRI remained significantly related to decline on the DMS at the 12s delay (p=0.018). Conclusion This preliminary study shows a significant association between higher sTNFRI and lower scores on the short-term visual memory delayed match to sample test in breast cancer patients receiving chemotherapy, supporting the hypothesis that sTNFRI is involved in CRCI. Graphical abstract Display Omitted Highlights ? First study to examine association between inflammation and CRCI during chemotherapy treatment. ? Assessed TNF-α, IL-6, IL-8, sTNFR1, sTNFR2, and IL6R in relation to multiple cognitive domains. ? Increasing sTNFRI concentrations are associated with worse short-term visual memory. ? This association remained after adjustment for age, education, stage, & anthracycline exposure.
机译:摘要背景癌症相关的认知障碍(CRCI)通常与化疗有关。据信慢性炎症增加,在与化疗相关的CRCI开发中发挥关键作用,但在接受化疗的患者中特别评估该假设的研究是罕见的。方法,我们使用目前接受化疗的二十二乳腺癌患者中的剑桥神经心理学测试自动电池(Cantab)评估了几个认知域。我们还使用Luminex测定测量患者血清中的炎症细胞因子和受体(MCP-1,TNF-α,STNFRI,STNFRII)浓度。将这些浓度对数转化以获得正态分布。使用Pearson相关性和线性回归评估了对数转化的细胞因子和认知之间的关联,同时考虑到相关的协变量。结果STNFri和STNFRII的浓度增加与CANDAB延迟匹配与样品(DMS,测试可视存储器)的性能相关。随着12秒(S)延迟(r = 0.65,p = 0.001),增加STNFRI水平与DMS百分比均正确(r = 0.47,p = 0.029)和DMS百分比正确相关(R = 0.65,p = 0.001)。在12S延迟后,增加的STNFRII水平与DMS百分比均相关(R = 0.57,P = 0.006)。在控制相关人口(即年龄,教育)和临床变量(即疾病阶段,方案类型)之后,我们发现增加的STNFri仍然与12S延迟下DMS的下降显着相关(P = 0.018)。结论这项初步研究表明,在短期视觉记忆延迟与接受化疗的乳腺癌患者的样本试验中,在短期视觉记忆延迟匹配之间的显着关联与乳腺癌患者的样本试验,支持STNFRI参与CRCI的假设。图形抽象显示省略了亮点?第一研究化疗治疗期间炎症与CRCI之间的关联。还评估TNF-α,IL-6,IL-8,STNFR1,STNFR2和IL6R相对于多重认知结构域。还增加STNFri浓度与较差的短期视觉记忆有关。还这种关联在调整年龄,教育,阶段和蒽环氯丁林暴露后仍然存在。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号